ASSOCIATION OF P2RY12 GENE POLYMORPHISM WITH ARTERIAL HYPERTENSION AMONG MILITARY PERSONNEL
Keywords:
P2RY12 gene polymorphism, arterial hypertension in military personnel, genetic predisposition, cardiovascular diseasesAbstract
The results of the study showed that the heterozygous H1/H2 genotype was most common among servicepersons with AH, indicating its association with an increased risk of the disease. In the control group, the homozygous H1/H1 genotype prevailed, indicating its lower frequency among individuals with AH. Correlation analysis confirmed the association between the heterozygous genotype and a more severe degree of hypertension, which allows us to consider it an important factor for assessing the severity of the disease. H2 allele genotypes showed no significant association with the development or severity of AH. Thus, the importance of P2RY12 gene polymorphism as a possible marker of predisposition to arterial hypertension is confirmed. Thus, the results may serve as a basis for the development of new methods of early diagnosis and prevention of AH, as well as for the creation of personalized programmes of treatment and control of the disease, which will significantly increase the effectiveness of preventive measures among military personnel and other population groups.
References
World Health Organization (WHO). (2021). Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization.
Sorrentino, S., et al. (2020). Genetic variations in P2RY12 and their implications in platelet aggregation. Journal of Clinical and Experimental Cardiology, 45(3), 231-245.
Wang, L., et al. (2019). Genetic variants in P2RY12 and their impact on vascular regulation and hypertension. Hypertension Research, 42(5), 455-463.
Khera, A. V., et al. (2020). Genome-wide association study of 1.5 million people identifies 538 loci associated with blood pressure traits. Nature, 581(7806), 403-412.
Cheng, H., et al. (2021). The Association of P2RY12 Polymorphisms with Cardiovascular Diseases: A Review of the Literature. Cardiovascular Genetics, 12(2), 102-110.
Morris, J. S., et al. (2022). P2Y Receptor Signaling in Hypertension: Molecular Mechanisms and Clinical Implications. Hypertension Research, 45(3), 215-222.
Kumar, S., et al. (2023). Impact of P2RY12 Gene Variants on Hypertension Risk: A Genomic Approach. Journal of Hypertension, 41(5), 1042-1050.
Zhang, L., et al. (2022). Protective Genetic Variants and Their Role in Cardiovascular Disease Resistance in Hypertensive Populations. Journal of Clinical Genetics, 37(1), 77-85.
Li, Q., et al. (2020). Correlation between P2RY12 Receptor Variants and Hypertension Severity in a Chinese Population. American Journal of Hypertension, 33(4), 345-353.
Smith, L. R., et al. (2022). Genetic Variants in Platelet Function and Their Role in Hypertension. Journal of Clinical Hypertension, 24(6), 453-460.
